Project Grant R01AI189698
Award Date 6/2/26
Completion Date 5/31/31
Dollars Obligated $678K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Ann Arbor, MI 48109, USA
Similar Awards
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $438,038 to the Regents of the University of California, Berkeley, under the Allergy and Infectious Diseases Research program (CFDA 93.855) for a two-year project period running from July 15, 2025 through June 30, 2027. This Project Grant funds a molecular research initiative investigating the regulation of infectious spore formation in Coccidioides posadasii, the fungal pathogen...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the Regents of the University of Michigan a $194,400 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period April 1, 2026 through March 31, 2028. The award supports investigator-initiated biomedical research to advance understanding of organelle contact sites in macrophage antifungal responses, with particular focus on Candida albicans...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Arizona a Project Grant of $3,075,549 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 28, 2025, with a completion date of June 30, 2029. This research initiative investigates airway innate immune responses to Coccidioides infection, a serious fungal disease commonly known as valley fever that is expanding geographically across the United States. The research focuses on...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the Regents of the University of Michigan a $516,410 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective April 23, 2026, with completion scheduled for March 31, 2031. The research initiative focuses on developing precision biomaterials and drug delivery technologies to monitor and enrich antigen-specific immune cells in vivo, addressing a critical gap...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the Regents of the University of Michigan a $411,078 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period April 1, 2026 through March 31, 2028. This award supports research to discover and characterize novel antifungal compounds derived from symbiotic bacteria—microorganisms that naturally co-exist with eukaryotic hosts—as potential therapeutic...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the Regents of the University of Michigan $419,274 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 8, 2025, with a completion date of June 30, 2027. This Project Grant funds research to understand the influence of climate and environmental factors on blastomycosis incidence and seasonality in the Northern Great Lakes states. The research compiles and analyzes the...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the Regents of the University of Michigan a $425,226 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) on June 25, 2025, with a completion date of May 31, 2027. This research project investigates the engineering of trained innate immunity using biomaterial implants to establish feasibility and control systemic immune responses. The primary...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the Regents of the University of Michigan a $3.11 million Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 23, 2025, for a project period extending through June 30, 2029. This grant supports the development of next-generation concanamycin A (CMA) and concanamycin B (CMB) derivative compounds designed to inhibit HIV Nef protein, a viral factor that...
- Federal Grant Award Summary The University of Michigan received a $411,780 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), with an award date of February 3, 2026, and completion date of January 31, 2028. The research project, titled "Deciphering Virulence Determinants of Human-Pathogenic Atypical Toxoplasma Gondii," focuses on identifying and characterizing the molecular...
- Federal Grant Award Summary The University of Michigan's Regents, through the Office of Research and Sponsored Projects, received a $411,078 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) on April 7, 2026, with a completion date of March 31, 2028. The research project, titled "Modeling Dirty Timestamp Mice to Assess the Impact of Perinatal Exposure to Diverse Pathogenic...